TAK

#465
Takeda Pharmaceutical Company Limited American Depositary Share
15.9 7 USD
+9782.43%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
15.95
15.98
Yıllık Aralık
0.16
18.89
Günlük Değişim
+9782.43%
Aylık Değişim
-4.37%
6 Aylık Değişim
+10.06%
Yıllık Değişim
+12.58%
Önceki Kapanış
0.1 6
Open
15.9 7
Düşük
15.9 5
High
15.9 8
Hacim
809
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler Temettüler
Çeyreklik Yıllık
Gelir tablosu Bilanço Nakit akışı
Değer 20202021202220232024 TTM

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Haberler